BiOptic Inc. (6850.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$30.00 (-0.66%) as of
Key statistics
- Market cap
- 992.67M
- P/E (TTM)
- 111.11
- EPS (TTM)
- 0.27
- Dividend yield
- 1.66%
- 52-week range
- 28.90 – 47.50
- Profit margin
- 0.00%
- Volume
- 41.60k
About BiOptic Inc.
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Taipei City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.